Adolescent + adult ADHD, across the lifespan
ADHD Treatment Maplewood, NJ
ADHD Treatment Maplewood, NJ: Careful ADHD evaluation and medication follow-up for teens and adults. We talk through stimulant and non-stimulant medications, behavioral supports, and New Jersey rules for in-person visits when they apply.
ADHD treatment Maplewood NJ residents can start with a free 15-minute call, then a real evaluation rather than a fifteen-minute prescription visit.
APSARD adult-ADHD guidelines
NJ Schedule II rules followed
Combination pharmacotherapy expertise
If you are in crisis right now
Call or text 988 for free, confidential mental health crisis support — 24/7, every day. For a life-threatening emergency, call 911.
This clinic is an outpatient psychiatric practice and is not staffed for crisis response. Messages here are not monitored around the clock.
Other NJ mental health support lines:
NJ Mental Health Cares — 866-202-HELP (4357), 8am–8pm weekdays.
NAMI-NJ HelpLine — 866-626-4664, 9am–4pm weekdays.
2NDFLOOR youth helpline — 1-888-222-2228, 24/7.
If you are worried about a loved one rather than yourself, those lines will talk to you about how to help.
Evidence-based care, not a rushed prescription visit
ADHD is a neurodevelopmental condition characterized by persistent inattention, hyperactivity-impulsivity, or both, at levels disproportionate to developmental stage and causing functional impairment across two or more settings — school or work, home, relationships. Contrary to the public perception that attention deficit hyperactivity disorder ADHD is a childhood condition children grow out of, adult ADHD is real, common (roughly 4.4% of U.S. adults meet diagnostic criteria), and among the most treatable psychiatric conditions we see. It also has the largest treatment effect size of any class of psychiatric medication — stimulants produce greater symptom improvement than antidepressants produce in depression.
At Maplewood Mental Health Clinic, ADHD treatment starts with a real evaluation, not an assumption that stimulant medication is the answer. The first visit is a 60–90-minute assessment, follow-up care is substantive, and medication decisions happen inside an ongoing clinical relationship. That matters because attention problems can also come from anxiety, depression, mood disorders, trauma, sleep disorders, substance use, medical issues, or sleep disruption.
This page covers how we actually diagnose and treat ADHD at our Maplewood, NJ mental health clinic and over NJ-wide telehealth, following APSARD's first-ever adult ADHD guideline (2024) and AAP guidance for adolescents. It also addresses the questions that come up around current New Jersey Schedule II rules, the Ryan Haight Act, ongoing stimulant shortages, and the intersection of ADHD with anxiety, depression, and bipolar disorder.
ADHD Treatment for Maplewood Residents
In person at 1585 Springfield Avenue, Maplewood, NJ 07040 — free on-site parking.
Telehealth anywhere in NJ, when clinically appropriate and permitted for the medication involved.
Phone (908) 201-3904, Mon–Fri 9am–5pm.
Maplewood residents make up most of this practice, and patients travel in from across Essex and Union County for the evaluation. ADHD is one of several mental health conditions treated here, and the overlap with the others is the reason we keep it under one roof. If you are searching for ADHD treatment near Maplewood NJ, the in-person office is the anchor and telehealth fills in around it — which for Schedule II medication is not just convenience but a regulatory structure, explained in detail below.
Do you need an ADHD psychiatrist, or will a PMHNP do?
This question comes up constantly, so here is the plain answer. Board certified psychiatrists are physicians (MD or DO) with residency training in psychiatry. A PMHNP — Psychiatric Mental Health Nurse Practitioner — is an advanced practice registered nurse with graduate training in psychiatry, board certified through the ANCC. In New Jersey both types of health care providers evaluate, diagnose ADHD, and prescribe stimulant and non-stimulant medications.
For straightforward adolescent and adult ADHD, including complex comorbidity and combination pharmacotherapy, a board certified PMHNP is a fully appropriate prescriber, and appointment availability is usually better. Cases that genuinely benefit from an ADHD psychiatrist or a subspecialist include children under 12, suspected complex neurodevelopmental presentations requiring formal neuropsychological testing, and treatment-refractory cases after multiple failed medication trials. We say so when that is the situation rather than keeping the case.
How we evaluate ADHD and reach an ADHD diagnosis
An ADHD diagnosis is not a formality on the way to a prescription. It is the part that determines whether the rest of the treatment plan makes sense, and it is where a rushed evaluation does the most damage. Getting the diagnosis right also means naming what the symptoms are not — the same symptoms show up in mood disorders, sleep disorders, and thyroid disease, and a diagnosis reached without excluding those is a guess.
ADHD diagnosis is clinical. There is no single blood test, brain scan, or computer task that confirms or rules out ADHD — every validated tool is an adjunct to the clinical interview. The DSM-5-TR requires six or more symptoms of inattention and/or hyperactivity-impulsivity for at least six months at a severity inconsistent with developmental level. For adults, five symptoms are sufficient. At least some symptoms must have been present before age 12 — the childhood-onset criterion — gathered through history from the patient and, when possible, a corroborating informant such as a parent, old school records, or report cards.
ADHD symptoms are broader than most people expect, and the mental health field has spent decades correcting a picture drawn mostly from hyperactive boys. Inattentive symptoms include careless mistakes, difficulty sustaining attention, not listening when spoken to, failing to finish tasks, poor organization, avoiding sustained mental effort, losing things, distractibility, and forgetfulness in daily activities. Hyperactive-impulsive symptoms include fidgeting, leaving your seat, restlessness, difficulty doing things quietly, being driven by a motor, excessive talking, blurting out answers, difficulty waiting a turn, and interrupting. Adults often present with the internal version of these symptoms — mental restlessness rather than visible fidgeting, and a mind that will not settle on one thing long enough to finish it. Symptoms have to be present in more than one setting, which is why we ask about home and work rather than just the complaint that brought you in.
The ASRS v1.1 (Adult ADHD Self-Report Scale) is the most commonly used screener. A positive Part A — four or more items in the shaded boxes — warrants full diagnostic evaluation. The full ASRS and Conners Adult ADHD Rating Scale document severity and track response to treatment. For adolescents, the Vanderbilt Assessment Scales, parent and teacher versions, are standard.
The critical diagnostic step — the one most commonly skipped in fast-turn evaluations — is ruling out conditions that produce ADHD-looking psychological symptoms. Thyroid disease (especially hyperthyroidism), obstructive sleep apnea and other sleep disorders, and sleep disruption can all mimic or worsen attention problems during diagnosis; iron-deficiency anemia and vitamin B12 deficiency can do the same. Depression with prominent cognitive features can look almost identical in adults. Anxiety disorders produce attentional disruption. Substance use, especially cannabis and alcohol, affects focus and must be assessed honestly. We screen for all of these at the initial evaluation and order labs when history warrants. Missing an underlying thyroid problem and starting a stimulant instead is a common diagnostic failure worth an extra twenty minutes to avoid.
The treatment process, visit by visit
Knowing the shape of it in advance removes a lot of the friction.
Free 15-minute call. Fit, cost, insurance, and what an evaluation involves. No diagnosis and no prescriptions on this call.
Comprehensive evaluation, 60–90 minutes. DSM-5-TR criteria, ASRS or Conners, childhood history, medical and cardiovascular screen, medication history, substance use, and co-occurring conditions.
Shared decision on treatment options. Stimulant versus non-stimulant medications, methylphenidate versus amphetamine family, extended-release versus immediate-release, and the reasoning behind the first choice.
Titration. Follow-up at roughly 2 weeks, 4 weeks, and 8 weeks, adjusting dose against symptom response and tolerability. This is the medication management phase that most rushed practices skip.
Maintenance. Every 1–3 months once stable, with in-person visits at the intervals New Jersey requires for Schedule II medication.
Medication management continues at that cadence for as long as treatment does. We set explicit treatment goals at the start so follow-up helps you manage symptoms in the actual places ADHD is costing you, whether that is unfinished work, missed appointments, or the argument you keep having at home. Those goals are what we measure against, and they are revisited as your life changes rather than set once and forgotten.
Medication options for ADHD
Medication is first-line for moderate-to-severe ADHD, and evidence based treatment means matching the agent to the person rather than starting everyone in the same place. Within the medication class, the APSARD adult ADHD guideline and AAP pediatric guidance both rank stimulants as first-line; non-stimulant medications are appropriate alternatives or add-ons in specific clinical contexts.
Stimulants
Two families. The methylphenidate family — Ritalin (IR), Concerta (extended release), Focalin/dexmethylphenidate — is typically first-line in adolescents given slightly better tolerability data. The amphetamine family — Adderall (mixed amphetamine salts), Vyvanse (lisdexamfetamine, a prodrug with smoother pharmacokinetics), AZSTARYS (serdexmethylphenidate) — is commonly first-line in adults, with the APSARD guideline supporting either family as equivalent for most patients. Both are Schedule II controlled substances with DEA-regulated prescribing. Starting doses are deliberately low and titrated upward over weeks based on symptom response and tolerability.
Non-stimulant medications
Atomoxetine (Strattera) is a selective norepinephrine reuptake inhibitor with documented efficacy. It is non-controlled and therefore easier to prescribe in patients with substance use history, cardiovascular concerns, or tics. Full therapeutic effect takes 4–8 weeks, substantially longer than stimulants. Guanfacine (Intuniv) and clonidine (Kapvay) are alpha-2 agonists useful for prominent hyperactivity or tics and for combination add-on. Viloxazine (Qelbree) is a newer non-stimulant with a mechanism similar to atomoxetine. Non-stimulant medications are typically second-line unless contraindications to stimulants exist.
Combination pharmacotherapy
For patients whose response to monotherapy is incomplete, combination therapy — typically a stimulant plus a non-stimulant — has documented superiority. A 2024 meta-analysis shows a 67.65% remission rate for methylphenidate combined with atomoxetine, substantially higher than monotherapy with either agent alone. Combination therapy is also increasingly relevant given the ongoing Adderall and Vyvanse shortages: a lower-dose stimulant augmented with atomoxetine often maintains efficacy while reducing pure-stimulant exposure. Combination regimens require more careful monitoring, but the outcome data justifies the complexity for partial responders.
What's emerging
Centanafadine is a novel triple reuptake inhibitor in Phase 3 trials for adult ADHD, with an FDA action date in July 2026. If approved it would be a meaningful new option for patients who don't tolerate stimulants. Device-based treatments — the Monarch eTNS System, EndeavorRx, and investigational tDCS/rTMS protocols — have emerging evidence but aren't yet standard care. We track the field and discuss options as they mature.
What to expect on a stimulant
Stimulant side effects are predictable, usually mild, and largely manageable. The most common are reduced appetite (especially around lunch, resolving by dinner for most), mild sleep onset delay (take the dose earlier), and sleep disruption when timing or dose is off, transient headache (resolving within 1–2 weeks), mild blood pressure and heart rate elevation, and occasional dry mouth. Rebound symptoms — an irritability or low mood window as the medication wears off in the evening — can occur with short-acting stimulants and are usually addressed by switching to an extended-release formulation or adjusting timing.
Less common but important: cardiovascular effects warrant a baseline EKG in patients with family history of sudden cardiac death, known structural heart disease, or significant cardiovascular risk factors. Current guidelines do not recommend routine EKG screening in otherwise healthy patients, but we gather cardiovascular history at every intake. Stimulants are contraindicated in uncontrolled hypertension, advanced coronary disease, hyperthyroidism, or current glaucoma. Tics, new-onset or worsening, can occur; most resolve with dose reduction or a formulation switch.
Ongoing monitoring includes blood pressure and heart rate at every visit, weight in adolescents and growth in pre-adolescents, sleep quality, and mood. We re-administer the ASRS or Conners at intervals to track symptom response quantitatively. If cardiovascular numbers drift upward we address it — lower dosing, a formulation switch, or primary-care coordination.
Behavior therapy, executive function coaching, and skills training
Medication alone is effective for most ADHD patients, but medication plus behavior therapy or coaching produces better functional outcomes — particularly for executive-function skills that medication doesn't directly address: time management, organization, task initiation, working memory strategies. For adolescents and adults, Cognitive Behavioral Therapy adapted for ADHD (CBT-ADHD), ADHD coaching, and behavior-modification strategies round out a complete treatment plan.
Teresa provides brief supportive work and basic ADHD-specific coping strategies during medication management visits, which is where a good deal of the practical support actually happens. For structured CBT-ADHD, executive function coaching, or professional ADHD coaching, we refer to New Jersey licensed clinicians and certified coaches we trust. Skills training works best alongside medication rather than instead of it — the medication makes the skills learnable and restores enough focus to practise them, and the skills help patients manage symptoms between visits, in daily routines, and when a dose is missed. Sustained focus is the outcome patients notice first and value most.
For adolescents still in school, we help families connect to academic accommodations (504 plans, IEPs) and coordinate with school counselors so the support follows the child into the classroom when a formal written evaluation or letter is needed. Parent training in behavior management has strong evidence in younger adolescents and is an AAP-recommended component; we point families to programs that deliver it. For helping children under 12, we refer to child-psychiatry colleagues rather than stretching scope.
CHADD (Children and Adults with Attention-Deficit/Hyperactivity Disorder) is the primary peer-education and advocacy organization for ADHD families and a solid resource for non-clinical support and educational materials.
Emotional dysregulation — the symptom nobody warned you about
The DSM criteria are built around attention and hyperactivity, but for many adults the hardest part of ADHD is emotional dysregulation: outsized reactions that arrive faster than judgment does, frustration that goes from zero to full in seconds, and rejection sensitivity that makes ordinary feedback land like a verdict. Untreated ADHD-related dysregulation can feel like severe emotional distress even when the core diagnosis is ADHD rather than a primary mood disorder. It is not in the diagnostic criteria, but it is one of the most consistently reported symptoms of managing ADHD in daily life, and one of the most common reasons adults finally seek mental health care, and it does a great deal of damage to relationships and self esteem before anyone connects it to the diagnosis.
It also responds to treatment, and naming it out loud is often the first support a patient has had for it. Stimulants and non-stimulants both improve emotional regulation for many patients, and the improvement in emotional balance, along with stronger emotional well being, is often what people notice before they notice the attention change. Where emotional stability remains a problem after ADHD is adequately treated, that usually means something else is running alongside it — mood disorders, trauma, or anxiety — and we look rather than assume. Untreated mood disorders are the most common reason ADHD treatment underperforms.
Adolescents, adults, and older adults
Adolescents (12–17). ADHD in this age range frequently overlaps with anxiety, depression, learning differences, and early substance use — all of which we screen for at intake. Treatment usually combines medication with behavioral strategies tuned to academic and social demands. The AAP recommends stimulants as first-line for adolescents, with non-stimulants considered for specific contraindications. We see patients 12 and older; for children under 12 we refer to child-psychiatry colleagues.
Adults. Adult ADHD often shows up as career underperformance despite high intelligence, chronic late assignments, forgotten appointments, impulsive decisions with recurring negative outcomes, disorganization at home, and a co-occurring anxiety or depressive disorder that has been treated — often inadequately — without recognition of the underlying ADHD. Major life transitions tend to be when it surfaces: a promotion into management, a first child, graduate school, a divorce. ADHD does not appear at those moments — it stops being survivable at them, and the cost to work life and family life becomes visible all at once. APSARD's 2024 guideline is the first dedicated adult-ADHD practice guideline and has modernized expectations: many adults are treated to substantial functional improvement, not merely managed, so they can build a more fulfilling life.
Older adults. ADHD does not disappear with age. Older adults with persistent ADHD often present with decades of under-treatment and compensatory strategies that are breaking down. Medication choice weighs cardiovascular risk more heavily, and non-stimulant medications may be preferred where cardiovascular history is significant. We assess for emerging cognitive impairment carefully in this population, because new-onset inattention in an older adult is more likely cognitive decline than ADHD.
Comorbidity sequencing — mood first, then ADHD
ADHD rarely travels alone. Anxiety disorders, depression, bipolar disorder, learning disabilities, and substance use disorders each co-occur at elevated rates. The clinical question is sequencing: which condition do you treat first?
ADHD + anxiety. Stimulants can worsen anxiety in some patients, particularly where anxiety is undertreated. We typically treat the anxiety first with an SSRI, stabilize over 6–8 weeks, then layer in ADHD treatment. For patients with modest anxiety and prominent ADHD, a non-stimulant such as atomoxetine or guanfacine is often a better first choice — it addresses both to some degree without the anxiety-amplification risk. This anxiety depression overlap is the single most common comorbidity picture we see.
ADHD + depression. Treat the depression first unless it is mild and clearly secondary to ADHD-driven functional failures. A common pattern is an adult whose depression resolves substantially once ADHD is adequately treated, because the executive-function failures producing the chronic stress disappear. SSRIs and stimulants combine safely.
ADHD + bipolar disorder. This sequencing is critical. Stimulants can destabilize bipolar mood cycling, including precipitating mania. We stabilize the bipolar disorder first with a mood stabilizer, maintain stability for 3–6 months, then consider adding stimulant therapy with careful monitoring.
ADHD + substance use. Active uncontrolled substance use is a relative contraindication to stimulant prescribing. Non-stimulants, or extended-release stimulants with reduced abuse potential such as lisdexamfetamine, are generally preferred. Treating both conditions simultaneously with close monitoring and NJ PDMP review is often the most effective approach.
How ADHD shows up differently in girls and women
Girls and women are systematically under-diagnosed with ADHD, for reasons now well understood. The classic childhood picture — a hyperactive-impulsive boy who can't sit still — doesn't match most female presentations, which tend toward the inattentive subtype: daydreamy, quiet, disorganized, but not disruptive. School systems and clinicians trained on the hyperactive presentation miss the inattentive one. Many women arrive here in their thirties or forties having spent decades compensating through intelligence and conscientiousness, hitting the wall when job complexity or family demands exceed that capacity.
ADHD in women is also commonly comorbid with anxiety and depression, and frequently it is the ADHD that has been overlooked while the anxiety-and-depression label has been carried for years. Hormonal fluctuation across the menstrual cycle and perimenopause affects symptom severity — estrogen has dopaminergic effects, and the perimenopause transition in particular is when previously-compensated ADHD often becomes unmanageable. We think carefully about these patterns in every adult-woman intake.
What the evidence actually shows about non-medication options
The internet is full of non-medication ADHD claims. Some are evidence-based; most aren't.
Regular aerobic exercise has modest evidence for symptom improvement, especially in children and adolescents, and compounds benefits across mood, sleep, and cognitive reserve. Sleep hygiene is essential — insufficient or disrupted sleep amplifies every ADHD symptom, and getting sleep architecture right is sometimes the difference between "medication isn't working" and "medication is working well." Mediterranean-pattern diet has correlational evidence but no proven treatment effect. Omega-3 fatty acids have small effect sizes as adjunctive therapy, particularly in children — a reasonable addition, not a monotherapy.
Elimination diets, yoga, acupuncture, neurofeedback, and computer-based cognitive training have either inconsistent or absent evidence for ADHD symptom improvement. We don't discourage them if patients find them helpful, but we're honest about what the data shows. Claims that dietary changes alone can treat moderate-to-severe ADHD are not supported. A genuinely holistic approach means treating sleep, exercise, comorbidity, and skills alongside medication — not replacing evidence based treatment with supplements.
The telehealth rules for ADHD stimulants in New Jersey
ADHD stimulant prescribing sits at the intersection of federal and state regulation, and New Jersey changed its rules more than once during 2026. Here is where things stand — but confirm current requirements at your consultation rather than relying on any web page, including this one.
Adults on Schedule II stimulants. Under New Jersey's 2026 framework for adult stimulants, the initial examination may be conducted by telemedicine. An in-person visit is then required within 30 days of that initial examination, with in-person visits every three months thereafter and at least one annually. This replaced the earlier rule requiring an in-person exam before any Schedule II prescribing began.
Other Schedule II medications. For Schedule II controlled substances generally, the baseline remains an initial in-person examination followed by in-person visits every three months.
Patients under 18. New Jersey maintains a minor-patient exception for stimulants: the in-person requirement can be waived where the clinician uses interactive real-time audio-video technology and obtains written parent or guardian consent. In practice many adolescents still benefit from at least one in-person visit.
Federal rules. DEA telemedicine flexibilities for controlled substances were extended again through 2026. New Jersey requirements apply regardless of federal flexibility, so the state rules above are the binding ones here.
NJ Prescription Drug Monitoring Program. Before every Schedule II prescription we check the NJ PDMP — a regulatory requirement and a safety check that identifies concurrent controlled-substance prescribing, doctor-shopping patterns, or diversion concerns. Patterns prompt a conversation, not a reflexive denial.
Stimulant shortages. The Adderall and Vyvanse shortages that began in 2022 continue with episodic supply disruption. When a preferred medication is unavailable we identify equivalent alternatives — generic methylphenidate ER, Concerta, Focalin XR, AZSTARYS, alternative amphetamine formulations — and coordinate with pharmacies to find the closest in-stock option. Combination regimens with non-stimulant augmentation sometimes allow lower stimulant doses that are easier to source.
Hybrid telehealth plus in-person care
Most ADHD patients here settle into a predictable rhythm: an evaluation, in-person visits at the intervals New Jersey requires for Schedule II medication, and telehealth in between. That structure satisfies the regulations while minimizing commute overhead that many working adults can't realistically absorb.
Bringing prior records — old psychoeducational evaluations, report cards with teacher comments about attention, a primary-care provider's notes — substantially accelerates the evaluation. If you have none of that, come anyway; we can gather most of it during the visit and follow up for records with your written consent afterward.
Cost and insurance
Free 15-minute call — no charge, no obligation, no insurance billing.
Comprehensive ADHD evaluation — $210, about 90 minutes.
Follow-up visit — $130, about 30 minutes.
Eighteen insurance plans are listed on our main page, covering most major mental health benefits in New Jersey. Because directories lag behind real credentialing status, we verify your specific plan during the free call before any paid visit. If your plan is not listed, ask about a superbill for out-of-network reimbursement or about the sliding scale, which reduces self-pay rates by 20% to 50% depending on your situation.
Comprehensive ADHD treatment does not have to mean an open-ended bill. The evaluation is a known number, follow-ups are a known number, and the visit cadence is set by clinical need and state regulation rather than by revenue.
Questions patients ask about ADHD treatment
Can adults really have ADHD?
Yes. Roughly 4.4% of U.S. adults meet diagnostic criteria. ADHD is a neurodevelopmental condition that begins in childhood, but it does not end there — the hyperactivity often becomes internal restlessness while the attention and executive-function difficulty persists. Many adults are diagnosed only after a child of theirs is.
Can you diagnose ADHD via telehealth?
Yes. Diagnosis is clinical — interview, validated rating scales, childhood history, and ruling out mimics — and all of that can be done by video. What telehealth cannot do is substitute for the in-person visits New Jersey requires once Schedule II medication is part of the plan.
Can you prescribe Adderall or Vyvanse via telehealth in NJ?
Partly. Under New Jersey's current adult-stimulant framework the initial examination may be by telemedicine, with an in-person visit required within 30 days and periodic in-person visits after that. Adolescents have a separate exception requiring written parental consent. These rules changed more than once in 2026, so we confirm the current requirement at your consultation rather than promising a specific arrangement in advance.
What if my adolescent has ADHD?
We see patients 12 and older. Evaluation includes Vanderbilt scales from parents and, where possible, teachers. Treatment usually pairs medication with school accommodations and behavioral strategies, and families are involved throughout. For children under 12 we refer to child psychiatry — younger children are better served by clinicians who see them all day.
What if I can't get my stimulant filled?
Call us rather than going without. We can often switch to an equivalent formulation that is in stock, adjust to a combination regimen at a lower stimulant dose, or send the prescription to a pharmacy that has supply. Abrupt discontinuation isn't dangerous the way some withdrawals are, but the symptom return is disruptive and avoidable.
Is there a non-medication treatment for ADHD?
CBT adapted for ADHD, executive function coaching, and skills training all have real evidence and help with the organizational skills medication doesn't directly fix. Non-medication approaches can also support emotional well being when they improve routines, coping, and follow-through. For mild ADHD they are sometimes sufficient on their own. For moderate-to-severe ADHD the evidence favors medication first, with behavioral work alongside.
What's the best medication for adult ADHD?
There isn't one best. APSARD treats the methylphenidate and amphetamine families as broadly equivalent for most adults, so the choice comes down to your history, comorbidity, cardiovascular picture, substance-use history, and how you respond to the first trial. Most people find their answer within two or three adjustments.
Does ADHD medication cause weight loss?
Appetite suppression is common early and often settles. Some weight loss can occur, more so in adolescents, which is why we track weight and growth at visits. If it becomes clinically significant we adjust — dosing schedule, formulation, or a non-stimulant.
How long will I have to take ADHD medication?
ADHD is generally lifelong, but treatment is not automatically permanent. Some patients take medication for years, some only during demanding periods, and some stop once skills and structures are solid. We revisit it rather than assuming.
What if I have ADHD and anxiety or depression too?
That is the norm, not the exception, and sequencing matters — usually mood or anxiety first, then ADHD. Managing both in one practice avoids the fragmentation that happens when two prescribers each treat half the picture, and treating both well can also improve emotional well being. One plan, one record, one relationship.
Do you offer partial hospitalization or an intensive program?
No. This is an outpatient mental health clinic, and partial hospitalization is a different level of care entirely. If your situation needs partial hospitalization, an intensive outpatient program, or inpatient care — uncommon for ADHD alone, but it happens with severe co-occurring conditions or severe emotional symptoms — we will say so and help arrange the referral rather than stretch outpatient care past what it can hold. Partial hospitalization and intensive outpatient programs across New Jersey take referrals directly, and we will make the call with you rather than handing you a list.
How do I get an ADHD diagnosis as an adult?
Book the free call, then the evaluation. Bring whatever childhood evidence you have — report cards, an old evaluation, a parent willing to answer questions. An adult ADHD diagnosis rests on current symptoms plus evidence that some were present before age 12, so that history is the piece most people underestimate. If the evidence points somewhere other than ADHD, we will tell you that too.
Ready to stop white-knuckling focus?
ADHD is one of the most treatable conditions in mental health — most patients see substantial improvement in focus, follow-through, and daily life within 4–8 weeks of an adequate medication trial, helping them move toward a more fulfilling life. Comprehensive ADHD treatment is less about the prescription than about the diagnosis being right and the follow-up being real. The free 15-minute call is how most of our patients start, and it is a reasonable first step whether the ADHD is yours or a loved one's.
Maplewood Mental Health Clinic · 1585 Springfield Avenue, Maplewood, NJ 07040 · (908) 201-3904
If you are in crisis, call or text 988 — 24/7, every day. For a life-threatening emergency, call 911.
Take the next step.
Start with a free 15-minute call. We will talk through fit, timing, and insurance — there's no obligation to book an evaluation after the call.